Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Science. 2024 Feb 2;383(6682):eadi5798. doi: 10.1126/science.adi5798. Epub 2024 Feb 2.
Science. 2024.
PMID: 38301010
Targeted Therapy Development in Acute Myeloid Leukemia.
Totiger TM, Ghoshal A, Zabroski J, Sondhi A, Bucha S, Jahn J, Feng Y, Taylor J.
Totiger TM, et al.
Biomedicines. 2023 Feb 20;11(2):641. doi: 10.3390/biomedicines11020641.
Biomedicines. 2023.
PMID: 36831175
Free PMC article.
Review.
Item in Clipboard
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance.
Sondhi AK, Risso CB, Taylor J.
Sondhi AK, et al.
Transl Cancer Res. 2023 Oct 31;12(10):2442-2447. doi: 10.21037/tcr-23-1247. Epub 2023 Oct 10.
Transl Cancer Res. 2023.
PMID: 37969398
Free PMC article.
No abstract available.
Item in Clipboard
New means and challenges in the targeting of BTK.
Nawaratne V, Sondhi AK, Abdel-Wahab O, Taylor J.
Nawaratne V, et al. Among authors: sondhi ak.
Clin Cancer Res. 2024 Apr 5. doi: 10.1158/1078-0432.CCR-23-0409. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38578606
Item in Clipboard
Cite
Cite